Empagliflozin May Slow Diabetic Retinopathy

Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 diabetes and a history of nonproliferative diabetic retinopathy, a US-based cohort study found.
Medscape Medical News